Sublingual immunotherapy vs control
Serious adverse events Weighted mean duration of studies: 49 weeks · people with asthma
Sublingual immunotherapy showed no clear difference in serious adverse events Weighted mean duration of studies: 56 weeks compared with control (moderate certainty).
1 finding from 1 review
- no estimate extracted29 studies · 4810 participantsModerate